Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 10 studies | 25% ± 9% | |
| epithelial cell | 4 studies | 23% ± 4% | |
| endothelial cell | 3 studies | 22% ± 5% | |
| astrocyte | 3 studies | 27% ± 2% | |
| glutamatergic neuron | 3 studies | 42% ± 14% | |
| oligodendrocyte | 3 studies | 19% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 29% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 3726.77 | 245 / 245 | 100% | 14.05 | 502 / 502 |
| thymus | 100% | 4727.92 | 653 / 653 | 100% | 15.17 | 604 / 605 |
| brain | 100% | 2354.03 | 2631 / 2642 | 100% | 12.16 | 705 / 705 |
| adrenal gland | 100% | 3042.63 | 258 / 258 | 100% | 16.22 | 229 / 230 |
| uterus | 100% | 3178.05 | 170 / 170 | 100% | 9.93 | 457 / 459 |
| ovary | 100% | 3172.52 | 180 / 180 | 100% | 13.68 | 428 / 430 |
| esophagus | 100% | 2084.41 | 1445 / 1445 | 99% | 12.00 | 182 / 183 |
| stomach | 100% | 2131.92 | 359 / 359 | 99% | 9.75 | 284 / 286 |
| intestine | 100% | 2334.95 | 966 / 966 | 99% | 10.63 | 522 / 527 |
| bladder | 100% | 2240.29 | 21 / 21 | 99% | 11.00 | 498 / 504 |
| breast | 100% | 2034.14 | 459 / 459 | 98% | 10.49 | 1097 / 1118 |
| pancreas | 100% | 1465.09 | 327 / 328 | 98% | 10.97 | 174 / 178 |
| lung | 100% | 2364.34 | 578 / 578 | 97% | 8.10 | 1121 / 1155 |
| kidney | 100% | 2737.91 | 89 / 89 | 97% | 8.68 | 871 / 901 |
| skin | 100% | 1634.85 | 1801 / 1809 | 97% | 7.57 | 458 / 472 |
| liver | 100% | 1589.40 | 225 / 226 | 90% | 5.20 | 365 / 406 |
| eye | 0% | 0 | 0 / 0 | 100% | 8.51 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 8.27 | 29 / 29 |
| spleen | 100% | 2902.68 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 13.62 | 1 / 1 |
| adipose | 100% | 1621.66 | 1199 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1616.92 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 974.17 | 825 / 861 | 0% | 0 | 0 / 0 |
| muscle | 94% | 979.90 | 751 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 7.16 | 41 / 45 |
| peripheral blood | 89% | 819.32 | 827 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0000976 | Molecular function | transcription cis-regulatory region binding |
| Gene name | MZF1 |
| Protein name | Myeloid zinc finger 1 Myeloid zinc finger 1 (MZF-1) (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42) |
| Synonyms | ZSCAN6 ZNF42 MZF |
| Description | FUNCTION: Binds to target promoter DNA and functions as a transcription regulator. Regulates transcription from the PADI1 and CDH2 promoter. May be one regulator of transcriptional events during hemopoietic development. . |
| Accessions | ENST00000596039.1 ENST00000599369.5 [P28698-1] ENST00000594108.1 ENST00000215057.7 [P28698-1] P28698 M0R1U5 ENST00000594234.5 [P28698-3] M0R2C0 |